Project description
Patient engagement with drug-related disabilities since the 1960s
Since 1960, patients have been involved in antenatal drug use, prompting urgent political and scientific discussions. This involvement has sparked conflicts among experts from both the Global South and North, including regions such as Latin America, Central Africa, India, and Europe. These interactions have driven advancements in reproductive health approaches, addressing democratic and civil challenges beyond traditional expert-led risk management. The ERC-funded BT project will examine how patient engagement with drug-related disabilities has evolved since the 1960s, reshaping concepts of reproductive health. It will analyse patient involvement in antenatal drug use and its political and scientific implications, focusing on monitoring birth defect factors, managing antenatal drug risks, marketing pharmaceuticals, and legal actions.
Objective
Beyond Thalidomide will trace the historical rise of patient engagement with drug related disability through the second half of the twentieth century to understand how a novel empowered group transformed conceptions of (reproductive) health and disease in science and society. The project will map the conditions in which patient became engaged with antenatal drug use, and reconstruct how their action has created political and scientific urgency since 1960. This multifaceted engagement resulted in clashes of expertise that connected actors in the Global South and North, from Latin American countries through Central Africa, India, and Europe, and the enforcement and stabilization of the development of approaches in reproductive health in the light of the democratic and civil societal challenges they pose, beyond traditional accounts of expert-led, iatrogenic risk management.
BT will address these aims trough analysis of four interlinked fields of patient engagement:
1. Monitoring, and the surveillance of exogenous factors for birth defects
2. Prevention, and the management of risks of antenatal drug use in health care systems
3. Marketing, and the making of pharmaceutical products
4. Legal Action, and court intervention
Mapping these fields of acting, BT will create an ambitious digital collection of patient life stories and a comprehensive integrated record of how patients engage. BT will, or the first time, deliver a global history of drug related disability from below, which examines the shifting contours of patients as actors. This project takes a ground-breaking approach to the historiography of reproductive health, combining high-impact global case studies with innovative research tools to explore the political, ethical and social challenges of this alternative perspective.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.1 - European Research Council (ERC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-ERC - HORIZON ERC Grants
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) ERC-2023-STG
See all projects funded under this callHost institution
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1010 WIEN
Austria
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.